Pharmafile Logo

TVF Communications

- PMLiVE

Hanover Health appoints two new associate directors

Donna Curran joins the communications team and Mark MacDonald joins the public affairs practice

Roche Basel Switzerland

Roche reports strong diagnostics sales in Q1 as demand for COVID-19 tests continues

Company continues to report a significant impact of biosimilar competition on established brands

- PMLiVE

Havas Health & You appoints Pat Thistlethwaite as chief experience officer

In addition to taking on the new role, Thistlethwaite will continue to serve as managing director

Empowering patients empowers results

Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials

- PMLiVE

Vertex to lead development of CRISPR Therapeutics-partnered gene therapy

Amended agreement sees Vertex take control of gene therapy programme

- PMLiVE

EMA finds overall benefit-risk ‘remains positive’ for J&J COVID-19 vaccine

Safety committee finds possible link to ‘very rare cases’ of unusual blood blots with low blood platelets

- PMLiVE

Health leaders welcome EDPB’s opinion on adequacy of UK’s data protection standards

Opinion ‘paves way’ for sharing of health data between EU and the UK

- PMLiVE

bluebird bio anticipates lift of clinical holds on LentiGlobin in mid-2021

Previously reported case of MDS in phase 1/2 study has been re-classified as transfusion-dependent anaemia

- PMLiVE

WHO director-general says pandemic can be brought under control within months

World has tools to curb pandemic if applied ‘consistently and equitably’

- PMLiVE

NICE sets out plans for ‘ambitious’ five-year strategy

NICE refocuses on reducing health inequalities and accelerating access to the latest and most effective treatments

- PMLiVE

Janssen will not seek regulatory approval for Erleada plus Zytiga in prostate cancer

Decision follows mixed results from the phase 3 ACIS study

- PMLiVE

In sickness and in health

If prevention is better than cure, we will need to help it along

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links